Repeated prolonged moderate-intensity walking exercise does not appear to have harmful effects on inflammatory markers in patients with inflammatory bowel disease

References

• Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369(9573):1641–1657.
   PubMed Web of Science ®Google Scholar
• Engels M, Cross RK, Long MD. Exercise in patients with inflammatory bowel diseases: current perspectives. Clin Exp Gastroenterol. 2018;11:1–11.
   PubMed Web of Science ®Google Scholar
• Gatt K, Schembri J, Katsanos KH, et al. Inflammatory bowel disease [IBD] and physical activity: a study on the impact of diagnosis on the level of exercise amongst patients with IBD. J Crohns Colitis. 2019;13(6):686–692.
   PubMed Web of Science ®Google Scholar
• DeFilippis EM, Tabani S, Warren RU, et al. Exercise and self-reported limitations in patients with inflammatory bowel disease. Dig Dis Sci. 2016;61(1):215–220.
   PubMed Web of Science ®Google Scholar
• Narula N, Fedorak RN. Exercise and inflammatory bowel disease. Can J Gastroenterol. 2008;22(5):497–504.
   PubMed Web of Science ®Google Scholar
• Eckert KG, Abbasi-Neureither I, Koppel M, et al. Structured physical activity interventions as a complementary therapy for patients with inflammatory bowel disease – a scoping review and practical implications. BMC Gastroenterol. 2019;19(1):115.
   PubMed Web of Science ®Google Scholar
• Jones PD, Kappelman MD, Martin CF, et al. Exercise decreases risk of future active disease in patients with inflammatory bowel disease in remission. Inflamm Bowel Dis. 2015;21(5):1063–1071.
   PubMed Web of Science ®Google Scholar
• Codella R, Luzi L, Terruzzi I. Exercise has the guts: how physical activity may positively modulate gut microbiota in chronic and immune-based diseases. Dig Liver Dis. 2018;50(4):331–341.
   PubMedGoogle Scholar
• Bilski J, Mazur-Bialy A, Brzozowski B, et al. Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence. Pharmacol Rep. 2016;68(4):827–836.
   PubMed Web of Science ®Google Scholar
• Monda V, Villano I, Messina A, et al. Exercise modifies the gut microbiota with positive health effects. Oxid Med Cell Longev. 2017;2017:3831972.
   PubMed Web of Science ®Google Scholar
• Pedersen BK, Steensberg A, Fischer C, et al. Exercise and cytokines with particular focus on muscle-derived IL-6. Exerc Immunol Rev. 2001;7:18–31.
   PubMed Web of Science ®Google Scholar
• Brown M, McClean CM, Davison GW, et al. The acute effects of walking exercise intensity on systemic cytokines and oxidative stress. Eur J Appl Physiol. 2018;118(10):2111–2120.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Nakaji S, Yamada M, et al. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev. 2002;8:6–48.
   PubMed Web of Science ®Google Scholar
• Pedersen BK. Special feature for the olympics: effects of exercise on the immune system: exercise and cytokines. Immunol Cell Biol. 2000;78(5):532–535.
   PubMed Web of Science ®Google Scholar
• Terink R, Bongers CCWG, Witkamp RF, et al. Changes in cytokine levels after prolonged and repeated moderate intensity exercise in middle-aged men and women. Transl Sports Med. 2018;1(3):110–119.
   Google Scholar
• D'Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(12):2218–2224.
   PubMed Web of Science ®Google Scholar
• Kostas A, Siakavellas SI, Kosmidis C, et al. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. WJG. 2017;23(41):7387–7396.
   PubMed Web of Science ®Google Scholar
• Wendel-Vos GC, Schuit AJ, Saris WH, et al. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol. 2003;56(12):1163–1169.
   PubMed Web of Science ®Google Scholar
• Klare P, Nigg J, Nold J, et al. The impact of a ten-week physical exercise program on health-related quality of life in patients with inflammatory bowel disease: a prospective randomized controlled trial. Digestion. 2015;91(3):239–247.
   PubMed Web of Science ®Google Scholar
• Arruda JM, Bogetz AL, Vellanki S, et al. Yoga as adjunct therapy for adolescents with inflammatory bowel disease: a pilot clinical trial. Complement Ther Med. 2018;41:99–104.
   PubMed Web of Science ®Google Scholar
• Tew GA, Leighton D, Carpenter R, et al. High-intensity interval training and moderate-intensity continuous training in adults with Crohn's disease: a pilot randomised controlled trial. BMC Gastroenterol. 2019;19(1):19.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. J Am Coll Cardiol. 2001;37(1):153–156.
   PubMed Web of Science ®Google Scholar
• Bennebroek Evertsz F, Hoeks CC, Nieuwkerk PT, et al. Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn's disease activity. J Clin Gastroenterol. 2013;47(10):850–856.
   PubMed Web of Science ®Google Scholar
• Bennebroek Evertsz F, Nieuwkerk PT, Stokkers PC, et al. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers. J Crohns Colitis. 2013;7(11):890–900.
   PubMed Web of Science ®Google Scholar
• Molenberghs G, Bijnens L, Shaw D. Linear mixed models and missing data. In: Verbeke MG, editor. Linear mixed models in practice. New York: Springer; 1997. p. 191–274.
   Google Scholar
• Riebe D, Ehrman JK, Liguori G, et al. ACSM's guidelines for exercise testing and prescription. Philadelphia: Wolters Kluwer; 2018. p. 143–179.
   Google Scholar
• Scherr J, Wolfarth B, Christle JW, et al. Associations between Borg's rating of perceived exertion and physiological measures of exercise intensity. Eur J Appl Physiol. 2013;113(1):147–155.
   PubMed Web of Science ®Google Scholar
• Verheggen R, Eijsvogels TMH, Catoire M, et al. Cytokine responses to repeated, prolonged walking in lean versus overweight/obese individuals. J Sci Med Sport. 2019;22(2):196–200.
   PubMed Web of Science ®Google Scholar
• Fischer CP. Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev. 2006;12:6–33.
   PubMed Web of Science ®Google Scholar
• Ploeger H, Obeid J, Nguyen T, et al. Exercise and inflammation in pediatric Crohn's disease. Int J Sports Med. 2012;33(08):671–679.
   PubMed Web of Science ®Google Scholar
• Cronin O, Barton W, Moran C, et al. Moderate-intensity aerobic and resistance exercise is safe and favorably influences body composition in patients with quiescent Inflammatory Bowel Disease: a randomized controlled cross-over trial. BMC Gastroenterol. 2019;19(1):29.
   PubMed Web of Science ®Google Scholar
• Cremer A, Ku J, Amininejad L, et al. Variability of faecal calprotectin in inflammatory bowel disease patients: an observational case-control study. J Crohns Colitis. 2019;13(11):1372–1379.
   PubMed Web of Science ®Google Scholar
• Du L, Foshaug R, Huang VW, et al. Within-stool and within-day sample variability of fecal calprotectin in patients with inflammatory bowel disease: a prospective observational study. J Clin Gastroenterol. 2018;52(3):235–240.
   PubMed Web of Science ®Google Scholar
• Calafat M, Cabre E, Manosa M, et al. High within-day variability of fecal calprotectin levels in patients with active ulcerative colitis: what is the best timing for stool sampling? Inflamm Bowel Dis. 2015;21(5):1072–1076.
   PubMed Web of Science ®Google Scholar
• Lasson A, Stotzer PO, Ohman L, et al. The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis. J Crohns Colitis. 2015;9(1):26–32.
   PubMed Web of Science ®Google Scholar
• Ng V, Millard W, Lebrun C, et al. Low-intensity exercise improves quality of life in patients with Crohn's disease. Clin J Sport Med. 2007;17(5):384–388.
   PubMed Web of Science ®Google Scholar
• Loudon CP, Corroll V, Butcher J, et al. The effects of physical exercise on patients with Crohn's disease. Am J Gastroenterol. 1999;94(3):697–703.
   PubMed Web of Science ®Google Scholar
• Elsenbruch S, Langhorst J, Popkirowa K, et al. Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom. 2005;74(5):277–287.
   PubMed Web of Science ®Google Scholar
• Gracie DJ, Williams CJ, Sood R, et al. Poor correlation between clinical disease activity and mucosal inflammation, and the role of psychological comorbidity, in inflammatory bowel disease. Am J Gastroenterol. 2016;111(4):541–551.
   PubMed Web of Science ®Google Scholar
• Walsh A, Kormilitzin A, Hinds C, et al. defining faecal calprotectin thresholds as a surrogate for endoscopic and histological disease activity in ulcerative colitis-a prospective analysis. J Crohns Colitis. 2019;13(4):424–430.
   PubMed Web of Science ®Google Scholar
• Ricanek P, Brackmann S, Perminow G, IBSEN II Study Group, et al. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers. Scand J Gastroenterol. 2011;46(9):1081–1091.
   PubMed Web of Science ®Google Scholar